Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arantxa Isla
Observed names:
A Isla,
A. Isla,
Arantxazu Isla
Institution:
University of the Basque Country
Observed institution:
University of the Basque Country
ORCID:
0000-0001-7575-2715
Observed ORCID:
0000-0001-7575-2715
OpenAlex ID:
A5015256484
Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration
2005
·
Alazne Arzuaga
, Javier Maynar
, et al.
·
The Journal of Clinical Pharmacology
·
336
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
2015
·
Eduardo Asín-Prieto
, Alicia Rodríguez-Gascón
, et al.
·
Journal of Infection and Chemotherapy
·
309
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
2018
·
Idoia Bilbao-Meseguer
, Alicia Rodríguez-Gascón
, et al.
·
Clinical Pharmacokinetics
·
289
The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
2021
·
Alicia Rodríguez-Gascón
, María Ángeles Solinís
, et al.
·
Pharmaceutics
·
149
PDF
Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs
2017
·
Ana Beloqui
, Ana del Pozo-Rodríguez
, et al.
·
Journal of Drug Delivery Science and Technology
·
109
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
2013
·
E. Asin-Prieto
, A. Rodriguez-Gascon
, et al.
·
Journal of Antimicrobial Chemotherapy
·
80
Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
2008
·
Arantxazu Isla
, Alicia Rodríguez-Gascón
, et al.
·
Clinical Pharmacokinetics
·
75
Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients
2005
·
Arantxazu Isla
, Javier Maynar
, et al.
·
The Journal of Clinical Pharmacology
·
69
Cefepime and continuous renal replacement therapy (CRRT): In vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients
2005
·
Arantxazu Isla
, Alicia Rodríguez Gascón
, et al.
·
Clinical Therapeutics
·
65
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
2013
·
Ana Beloqui
, María Ángeles Solinís
, et al.
·
Journal of Microencapsulation
·
60
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
2020
·
Helena Barrasa
, Amaia Soraluce
, et al.
·
International Journal of Infectious Diseases
·
55
PDF
37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3): Brussels, Belgium. 21-24 March 2017
2017
·
And Sepsis Study Group
, M. Von Seth
, et al.
·
Critical Care
·
49
PDF
Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries
2012
·
A. Canut
, A. Isla
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
49
Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC
2005
·
A. Isla
, A. Arzuaga
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
49
Medication errors in Parkinson's disease inpatients in the Basque Country
2017
·
Unax Lertxundi
, Arantxa Isla
, et al.
·
Parkinsonism & Related Disorders
·
45
Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
2020
·
Amaia Soraluce
, Helena Barrasa
, et al.
·
Pharmaceutics
·
44
PDF
Population pharmacokinetics of daptomycin in critically ill patients
2018
·
A. Soraluce
, E. Asín-Prieto
, et al.
·
International Journal of Antimicrobial Agents
·
44
Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria
2012
·
Eduardo Asín
, Arantxazu Isla
, et al.
·
International Journal of Antimicrobial Agents
·
42
Anticholinergic burden in Parkinson’s disease inpatients
2015
·
Unax Lertxundi
, Arantxazu Isla
, et al.
·
European Journal of Clinical Pharmacology
·
41
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function
2015
·
A. Canut
, A. Isla
, et al.
·
International Journal of Antimicrobial Agents
·
39
Vaginal gene therapy
2015
·
Alicia Rodríguez-Gascón
, Ana del Pozo-Rodríguez
, et al.
·
Advanced Drug Delivery Reviews
·
38
Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery
2012
·
Arantxazu Isla
, Iñaki F. Trocóniz
, et al.
·
European Journal of Clinical Pharmacology
·
38
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
2021
·
Idoia Bilbao-Meseguer
, Helena Barrasa
, et al.
·
Pharmaceutics
·
34
PDF
In vitro AN69 and Polysulphone Membrane Permeability to Ceftazidime and in vivo Pharmacokinetics during Continuous Renal Replacement Therapies
2007
·
Arantxazu Isla
, Alicia R. Gascón
, et al.
·
Chemotherapy
·
34
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
2018
·
Helena Barrasa
, Amaia Soraluce
, et al.
·
Journal of Critical Care
·
33
Show more works
View as search
Works count:
70
Citation count:
2,638
H-index:
30
I10-index:
43
Year
Topic
Type